Maura N. Dickler

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 1K citations · Full text

Medicine, Genetics, Oncology +14

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo et al. · Clinical Cancer Research · 2017 · 683 citations · Full text

Medicine, Oncology, Pharmacology +17

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Hope S. Rugo, R. Bryan Rumble, Erin Macrae et al. · Journal of Clinical Oncology · 2016 · 645 citations · Full text

Medicine, Endocrinology, Oncology +15